Free Trial

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Share Price Crosses Below 200-Day Moving Average - Should You Sell?

NorthWest Health Prop Real Est Inv Trust logo with Real Estate background

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN - Get Free Report)'s stock price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of C$4.78 and traded as low as C$4.72. NorthWest Health Prop Real Est Inv Trust shares last traded at C$4.80, with a volume of 694,166 shares traded.

Analyst Upgrades and Downgrades

Separately, National Bankshares boosted their price target on NorthWest Health Prop Real Est Inv Trust from C$5.50 to C$5.75 and gave the company an "outperform" rating in a research note on Tuesday, March 11th.

Get Our Latest Research Report on NWH.UN

NorthWest Health Prop Real Est Inv Trust Trading Up 0.2%

The company has a debt-to-equity ratio of 129.42, a quick ratio of 0.06 and a current ratio of 0.25. The company has a market cap of C$1.19 billion, a P/E ratio of -3.04, a P/E/G ratio of 0.74 and a beta of 1.05. The business's 50-day moving average price is C$4.84 and its 200 day moving average price is C$4.78.

NorthWest Health Prop Real Est Inv Trust Company Profile

(Get Free Report)

NorthWest Healthcare Properties Real Estate Investment Trust TSX: NWH.UN (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at June 30, 2020, the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 189 income-producing properties and 15.3 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand.

See Also

Should You Invest $1,000 in NorthWest Health Prop Real Est Inv Trust Right Now?

Before you consider NorthWest Health Prop Real Est Inv Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NorthWest Health Prop Real Est Inv Trust wasn't on the list.

While NorthWest Health Prop Real Est Inv Trust currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines